These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36761972)

  • 1. Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics.
    Peiffer L; Gambichler T; Buus TB; Horny K; Gravemeyer J; Furtmann F; Spassova I; Kubat L; Susok L; Stranzenbach R; Srinivas N; Ødum N; Becker JC
    Front Oncol; 2023; 13():1090592. PubMed ID: 36761972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA sequencing comparison of CD4+, CD8+ and TCR-γδ+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes.
    Chennareddy S; Rindler K; Ruggiero JR; Alkon N; Cohenour ER; Tran S; Weninger W; Griss J; Jonak C; Brunner PM
    Br J Dermatol; 2024 Aug; ():. PubMed ID: 39133553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling.
    Mehdi SJ; Moerman-Herzog AM; Wong HK
    J Vis Exp; 2021 Oct; (176):. PubMed ID: 34723945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA-sequencing reveals predictive features of response to pembrolizumab in Sézary syndrome.
    Su T; Duran GE; Kwang AC; Ramchurren N; Fling SP; Kim YH; Khodadoust MS
    Oncoimmunology; 2022; 11(1):2115197. PubMed ID: 36046812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
    Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
    Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors.
    Campbell JJ; Clark RA; Watanabe R; Kupper TS
    Blood; 2010 Aug; 116(5):767-71. PubMed ID: 20484084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas.
    Gaydosik AM; Stonesifer CJ; Khaleel AE; Geskin LJ; Fuschiotti P
    Clin Cancer Res; 2022 Jun; 28(12):2610-2622. PubMed ID: 35421230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single TCR-Vβ2 evaluation discloses the circulating T cell clone in Sezary syndrome: one family fits all!
    Scala E; Abeni D; Pomponi D; Russo N; Russo G; Narducci MG
    Arch Dermatol Res; 2015 Aug; 307(6):487-93. PubMed ID: 25733488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome.
    Moerman-Herzog A; Mehdi SJ; Wong HK
    Cells; 2020 Aug; 9(9):. PubMed ID: 32872487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
    Fierro MT; Novelli M; Quaglino P; Comessatti A; Fava P; Ortoncelli M; Ponti R; Bernengo MG
    Dermatology; 2008; 216(3):213-21. PubMed ID: 18182812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant and Benign T Cells Constituting Cutaneous T-Cell Lymphoma.
    Nakai S; Kiyohara E; Watanabe R
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidermotropic T cell lymphomas as models for tumor progression].
    Bagot M; Bensussan A
    Med Sci (Paris); 2006 Feb; 22(2):192-6. PubMed ID: 16457762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome.
    Roelens M; de Masson A; Andrillon A; Ram-Wolff C; Biard L; Boisson M; Mourah S; Battistella M; Toubert A; Bagot M; Moins-Teisserenc H
    Br J Dermatol; 2022 Jun; 186(6):1010-1025. PubMed ID: 35041763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin.
    Potoczna N; Boehncke WH; Nestle FO; Küenzlen C; Sterry W; Burg G; Dummer R
    J Cutan Pathol; 1996 Aug; 23(4):298-305. PubMed ID: 8864915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome analysis of Sézary syndrome and lymphocytic-variant hypereosinophilic syndrome T cells reveals common and divergent genes.
    Moerman-Herzog AM; Acheampong DA; Brooks AG; Blair SM; Hsu PC; Wong HK
    Oncotarget; 2019 Aug; 10(49):5052-5069. PubMed ID: 31489115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of cell adhesion molecule 1 and its splicing variants in Sézary cells and cell lines from cutaneous T-cell lymphoma.
    Yamaguchi M; Morizane S; Hamada T; Miyake T; Sugaya M; Iwata H; Fujii K; Haramoto-Shiratsuki R; Nakagawa Y; Miura M; Ohshima K; Morishita K; Takahashi T; Imada M; Okada K; Uehara J; Sowa-Osako J; Iwatsuki K
    J Dermatol; 2019 Nov; 46(11):967-977. PubMed ID: 31515833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation.
    Saulite I; Ignatova D; Chang YT; Fassnacht C; Dimitriou F; Varypataki E; Anzengruber F; Nägeli M; Cozzio A; Dummer R; Scarisbrick J; Pascolo S; Hoetzenecker W; Bobrowicz M; Guenova E
    Oncoimmunology; 2020; 9(1):1738797. PubMed ID: 32760603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.